Author
Listed:
- Koen Debackere
(Laboratory for Experimental Hematology, KU Leuven
Center for Cancer Biology, VIB)
- Lukas Marcelis
(Translational Cell & Tissue Research, KU Leuven)
- Sofie Demeyer
(Center for Cancer Biology, VIB
Center for Human Genetics, KU Leuven)
- Marlies Vanden Bempt
(Laboratory for Experimental Hematology, KU Leuven
Center for Cancer Biology, VIB
Center for Human Genetics, KU Leuven)
- Nicole Mentens
(Center for Cancer Biology, VIB
Center for Human Genetics, KU Leuven)
- Olga Gielen
(Center for Cancer Biology, VIB
Center for Human Genetics, KU Leuven)
- Kris Jacobs
(Center for Cancer Biology, VIB
Center for Human Genetics, KU Leuven)
- Michael Broux
(Center for Cancer Biology, VIB
Center for Human Genetics, KU Leuven)
- Gregor Verhoef
(Laboratory for Experimental Hematology, KU Leuven
University Hospitals Leuven)
- Lucienne Michaux
(Center for Human Genetics, KU Leuven
Center for Human Genetics, University Hospitals Leuven)
- Carlos Graux
(Mont-Godinne University Hospital)
- Iwona Wlodarska
(Center for Human Genetics, KU Leuven
Center for Human Genetics, University Hospitals Leuven)
- Philippe Gaulard
(Département de Pathologie, Groupe Hospitalier Henri Mondor, AP-HP
INSERM U955 and Université Paris-Est)
- Laurence Leval
(Institute of Pathology, Department of Laboratory Medicine and Pathology, Lausanne University Hospital and Lausanne University)
- Thomas Tousseyn
(Translational Cell & Tissue Research, KU Leuven
University Hospitals Leuven)
- Jan Cools
(Center for Cancer Biology, VIB
Center for Human Genetics, KU Leuven)
- Daan Dierickx
(Laboratory for Experimental Hematology, KU Leuven
University Hospitals Leuven)
Abstract
Peripheral T-cell lymphoma (PTCL) is a heterogeneous group of non-Hodgkin lymphomas with poor prognosis. Up to 30% of PTCL lack distinctive features and are classified as PTCL, not otherwise specified (PTCL-NOS). To further improve our understanding of the genetic landscape and biology of PTCL-NOS, we perform RNA-sequencing of 18 cases and validate results in an independent cohort of 37 PTCL cases. We identify FYN-TRAF3IP2, KHDRBS1-LCK and SIN3A-FOXO1 as new in-frame fusion transcripts, with FYN-TRAF3IP2 as a recurrent fusion detected in 8 of 55 cases. Using ex vivo and in vivo experiments, we demonstrate that FYN-TRAF3IP2 and KHDRBS1-LCK activate signaling pathways downstream of the T cell receptor (TCR) complex and confer therapeutic vulnerability to clinically available drugs.
Suggested Citation
Koen Debackere & Lukas Marcelis & Sofie Demeyer & Marlies Vanden Bempt & Nicole Mentens & Olga Gielen & Kris Jacobs & Michael Broux & Gregor Verhoef & Lucienne Michaux & Carlos Graux & Iwona Wlodarska, 2021.
"Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified,"
Nature Communications, Nature, vol. 12(1), pages 1-19, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24037-4
DOI: 10.1038/s41467-021-24037-4
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-24037-4. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.